Previous studies had found the IL-6 rapid diagnostic system to be well-suited for various clinical applications, including early diagnosis of respiratory failure risk in COVID-19 patients, differentiation of influenza severity in children, and early detection of acute wound infection (Lin et al., 2021; Pan et al., 2022; Wang et al., 2022). Here, IL6 is linked to COVID-19.